The trial will be conducted at up to seven US sites, enrolling 90 patients with advanced or metastatic solid tumours.
A partnership comprising TransCode Therapeutics and Quantum Leap Healthcare Collaborative has submitted an investigational ...
Participants will each receive a single intravenous infusion of AFTX-201 at doses determined from preclinical studies.
A New Approach Enabling Physicians to Treat Toenail Fungus at the Point-of-Care HSG 42 is highly differentiated. It is ...
Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study in the United States. The Phase I clinical trial aims to evaluate ...
Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has ...
SAN FRANCISCO and SUZHOU, China, Aug. 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing and ...
The MarketWatch News Department was not involved in the creation of this content. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--December 18, 2025-- Cartography Biosciences, Inc., a biotechnology ...